Benzodiazepine Taper With Cognitive Behavioral Therapy in Patients Using Prescription Opioids

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

April 13, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Anxiety Disorders
Interventions
COMBINATION_PRODUCT

Cognitive behavioral therapy for anxiety plus benzodiazepine taper

11 sessions of individual therapy consisting of exposure-based cognitive behavioral therapy that is designed specifically for assisting with benzodiazepine taper. This will be added to a gentle, 12-week benzodiazepine taper. CBT will be initiated for two sessions prior to the benzodiazepine taper initiation.

COMBINATION_PRODUCT

Health education control plus benzodiazepine taper

11 sessions of individual therapy control consisting of psychoeducational topics related to health and well-being, along with the gentle, 12-week benzodiazepine taper.

Trial Locations (3)

90025

UCLA Integrated Substance Abuse Programs, Los Angeles

90404

UCLA Family Health Center, Santa Monica

91505

UCLA Health MPTF Toluca Lake Primary Care, Burbank

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Boston University

OTHER

lead

University of California, Los Angeles

OTHER